mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |